Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06535347 · ClinicalTrials.gov registry record · NA
Nudging High-acuity Emergency Department Patients to Schedule a Follow-up Visit
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 6,814
- Enrollment target
NCT06535347: Completed NA study, sponsored by Geisinger Clinic.
NCT06535347 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 6,814 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (386% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06535347, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,814 participants
- Enrollment target
Study Summary
The goal of this campaign is to reduce unnecessary emergency department (ED) visits by encouraging patients with high acuity visits to follow up with an appropriate primary care provider (PCP) or specialist and therefore obtain appropriate care outside of the ED. In this campaign, patients will be assigned to receive or not receive outreach following ED discharge that is aligned with the goal. Outreach will occur via a text message and information added to the patient's after visit summary, and will include a contact number to schedule and hyperlink to allow self-scheduling. The study will assess whether ED use differs across patients in different outreach conditions. It will also examine whether patients followed through on the calls to action in the messages differently across conditions.
Primary Outcome
ED visit (yes/no)
Interventions
- BEHAVIORAL Information about scheduling a follow-up appointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,814 participants |
| Start Date | 2024-08-09 |
| Est. Completion | 2025-04-06 |
| Phase | NA |
What the finished NCT06535347 record still lists
NCT06535347 is an interventional study that assigns participants to a tested intervention. Its 6,814 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (386% higher).
The record links to 0 conditions, and to 1 intervention - of which Information about scheduling a follow-up appointment is the first listed.
NCT06535347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06535347 about?
NCT06535347 is a clinical study titled "Nudging High-acuity Emergency Department Patients to Schedule a Follow-up Visit". The goal of this campaign is to reduce unnecessary emergency department (ED) visits by encouraging patients with high acuity visits to follow up with an appropriate primary care provider (PCP) or specialist and therefore obtain appropriate care outside of the ED. In this campaign, patients will be a...
What is the current status of trial NCT06535347?
This trial is currently completed. It is a NA study. The enrollment target is 6,814 participants. The study started on 2024-08-09. Estimated completion is 2025-04-06.
What interventions are being tested in trial NCT06535347?
The interventions under investigation include: Information about scheduling a follow-up appointment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06535347?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06535347's enrollment target sits among peer trials
6,814 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT06234384 · 6,833 participants
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI